VA
ORGO icon

Verdad Advisers’s Organogenesis Holdings ORGO Stock Holding History

Verdad Advisers’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
+46,600
New +$114K 0.11% 183

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Verdad Advisers's ORGO Position: Q2 2026 in Review

Verdad Advisers opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 46,600 shares worth $113K. The stake represents 0.11% of the portfolio and ranks #183 among its holdings.

136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Verdad Advisers held 46,600 shares of Organogenesis Holdings worth $113K as of Q2 2026.
  • Organogenesis Holdings was a new Verdad Advisers position in Q2 2026.
  • Organogenesis Holdings made up 0.11% of Verdad Advisers's portfolio in Q2 2026, its #183 holding.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.